Properly Verified International Online Pharmacies Sell Genuine and Safe Medication
Last month, Roger Bate, a scholar at the American Enterprise Institute and head of the Safe Medicines Coalition, published the results of a study which tested and compared the quality of drugs purchased from online pharmacies in the U.S. and abroad, including pharmacies verified by third-parties and those not verified. The findings were clear: PharmacyChecker-approved international online pharmacies sell medications of comparable quality to U.S. online pharmacies verified by the National Association of Boards of Pharmacy (NABP) and LegitScript.
In fact, overall, the results were better for PharmacyChecker-verified pharmacies than for those verified by NABP and LegitScript. Results were dramatically worse for pharmacies with no third-party verification. The drug testing focused on generic versions of Lipitor (atorvastatin) and of generic Cipro (ciprofloxacin), which were ordered from the online pharmacies by the researchers. (more…)
Tagged with: Atorvastatin, CIPA, Cipro, Ciprofloxacin, LegitScript, Lipitor, NABP, Roger Bate, testing
LegitScript is again disseminating misinformation to discredit PharmacyChecker.com and its mission to help consumers safely access affordable medication, and we can bet that the very powerful pharmaceutical company interests LegitScript allies with are enjoying its efforts.
This week, LegitScipt’s John Horton blogged with apparent glee about charges by the U.S Attorney’s Office for Western Pennsylvania implicating several Canadian individuals and their company, Quantum Solutions, for allegedly exporting wholesale quantities of medications manufactured for foreign markets to U.S. pharmacists between 2007 and 2011.
Horton makes the mistake of saying that the case involved charges against an internet pharmacy certified by PharmacyChecker, but this is not the case. No online pharmacy is charged in the case, let alone any online pharmacy verified by PharmacyChecker.
Horton also states that the case involved the shipment of “bad” medicine, but there is nothing in the court documents indicating a problem with the quality of any of medications. Their labeling was apparently for the countries where they were being sold, which makes them “misbranded” if sold in the U.S. but not “bad” medicine. The drugs involved were expensive brand name drugs like Abilify, Zyprexa, and Plavix, costing hundreds of dollars per month in the U.S. but normally 80-90% lower in price outside the U.S. — which is likely what motivated the U.S. pharmacists to allegedly purchase the medication from abroad.
John Horton’s blog shows that in the world of online pharmacies, one party you can’t trust for reliable information is John Horton.
A very strange thing about the government’s filing in this case is an attachment listing website domains, a few of which are for international online pharmacies verified in our program. There is no claim of wrongdoing by any of these sites. The filing explains that these website addresses are property which the U.S. government seeks to have forfeited by the defendants in the event of a conviction, as the addresses may have been purchased with proceeds of the alleged offense. Certainly there are other assets owned by the defendants that our government could seek, so why focus on these uninvolved websites? It would seem that if these websites were taken by the government, the public would lose access to several safe, low-cost pharmacies.
Not surprisingly, John Horton misrepresents at least one of these pharmacies as being “the subject of today’s criminal charges” (more lies). Horton goes further by posting this list of websites to his blog in what we see as an attempt to smear the reputations of these uninvolved sites and part of his ongoing tactics to scare Americans away from safe and affordable medication and keep us hostage to inflated drug prices at home.
Tagged with: affordable prescriptions, brand name drugs, LegitScript
Americans Can’t Afford It.
Last week, an article was published by Jeremy Malcolm, senior global policy analyst for the Electronic Frontier Foundation, under the appropriate title, “How Big Pharma’s Shadow Regulation Censors the Internet.” Basically, Jeremy explains that due to drug company money and political influence in the United States, there are activities going on both in plain view and behind the scenes that are meant to curtail and even end access by Americans to lower cost medications being sold on the Internet.
I’ve been writing about this – albeit in less Internet policy, theoretical terms – for years and testified before and warned Congress in 2013 on this issue. About a month ago, I published an article on Circle ID, a source of news and opinion about Internet policy and governance, describing the actions of drug companies to dominate the Internet. My hope was to reach people just like Jeremy Malcolm at organizations like the Electronic Frontier Foundation (EFF). EFF is a non-governmental organization, founded in 1990 to defend civil liberties in the digital world. They champion “user privacy, free expression, and innovation through impact litigation, policy analysis, grassroots activism, and technology development.” Read about its awesome work and history here. (more…)
Tagged with: Alliance for Safe Online Pharmacies, Center for Safe Internet Pharmacies, Electronic Frontier Foundation, jeremy malcolm, LegitScript, NABP, shadow regulation, voluntary agreements